Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor… Grant US-11304932-B2 United States of America 19 Apr 2022
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A… Grant US-10787437-B2 United States of America 29 Sep 2020
Processes for the preparation of pyrazole derivatives useful as modulators of the 5-HT2A… Grant US-10059691-B2 United States of America 28 Aug 2018
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor… Grant US-10034859-B2 United States of America 31 Jul 2018
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor… Grant US-10022355-B2 United States of America 17 Jul 2018
Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline Grant US-9808455-B2 United States of America 07 Nov 2017
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor… Grant US-9775829-B2 United States of America 03 Oct 2017
Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of… Grant US-9763953-B2 United States of America 19 Sep 2017
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-p… Grant US-9745270-B2 United States of America 29 Aug 2017
Methods of maintaining, treating or improving cognitive function Grant US-9585877-B2 United States of America 07 Mar 2017
Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide… Grant US-9550767-B2 United States of America 24 Jan 2017
Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide… Grant US-9273044-B2 United States of America 01 Mar 2016
Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide… Grant US-9108961-B2 United States of America 18 Aug 2015
Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2… Grant US-8815933-B2 United States of America 26 Aug 2014
Crystalline form of (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide… Grant US-8710227-B2 United States of America 29 Apr 2014
Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2… Grant US-8642638-B2 United States of America 04 Feb 2014
Treatment of cognitive disorders with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2… Grant US-8569354-B2 United States of America 29 Oct 2013
TREATMENT OF COGNITIVE DISORDERS WITH CERTAIN ALPHA-7 NICOTINIC ACID RECEPTORS IN… Application US-20110124631-A1 United States of America 26 May 2011
Dosage formulations for acetylcholinesterase inhibitors Grant US-7939522-B1 United States of America 10 May 2011
A USE OF GALANTAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE; TARGETING THE UNDERLYING… Application WO-2001074364-A3 World Intellectual Property Organisation (WIPO) 16 May 2002
A USE OF GALANTAMINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE; TARGETING THE UNDERLYING… Application WO-2001074364-A2 World Intellectual Property Organisation (WIPO) 11 Oct 2001